Vitrakvi (larotrectinib, Bayer and Loo Oncology Inc)
Indications: treatment of adult and pediatric patients with solid tumors that:
Dosage:
Contraindications: None
FDA Approves Aprocitentan For Treatment of Uncontrolled High Blood Pressure
March 20th 2024Aprocitentan (TRYVIO) from pharmaceutical company Idorsia demonstrated statistically significant and clinically meaningful reductions in blood pressure in combination with other antihypertensive therapies.